Anticancer Drugs Could Make Immunotherapies More Effective (IMAGE)
Caption
Pretreatment with EZH2 inhibitor (top right) leads to higher recruitment of CAR-T cells (red) into the lymph node tumor compared with control (top left). Pretreatment with EZH2 inhibitor (bottom right) also leads to closer contacts between lymphoma B cells and T cells in culture.
Credit
Courtesy of the Béguelin lab
Usage Restrictions
N/A
License
Original content